Research advances in tumor markers for the diagnosis of hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is a malignant tumor with a high fatality rate in the world, and alpha-fetoprotein (AFP) is the most commonly used tumor marker for HCC diagnosis. However, AFP does not have a satisfactory sensitivity or specificity and may lead to missed diagnosis when the tumor is sm...
Main Author: | YANG Guimin |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Department of Journal of Clinical Hepatology
2018-01-01
|
Series: | Linchuang Gandanbing Zazhi |
Subjects: | |
Online Access: | http://www.lcgdbzz.org/qk_content.asp?id=8705 |
Similar Items
-
Research advances in serum biomarkers for early diagnosis of hepatocellular carcinoma
by: ZHU Mingyu
Published: (2014-10-01) -
Application of metabolomics in research on biomarkers for hepatocellular carcinoma
by: WANG Jiangang
Published: (2014-08-01) -
A Case of Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus Refractory to Epirubicin That Showed Marked Decrease in Tumor Markers after Transcatheter Arterial Infusion with Miriplatin
by: Hiroki Nishikawa, et al.
Published: (2011-06-01) -
Role of serum glypican-3 in the diagnosis and differentiation of small hepatocellular carcinoma from hepatitis-C virus cirrhosis
by: Eman A.E. Badr, et al.
Published: (2014-09-01) -
The progress of FibroScan technique for diagnosis of hepatocellular carcinoma value
by: LI Mi
Published: (2015-06-01)